𝗙𝗜𝗥𝗦𝗧 𝗔𝗟𝗭𝗛𝗘𝗜𝗠𝗘𝗥’𝗦 𝗕𝗟𝗢𝗢𝗗 𝗧𝗘𝗦𝗧:...

Discover how the first FDA-cleared blood test for Alzheimer’s disease, developed by Fujirebio,...

Overview of Alzheimer’s disease...

hello guys today's topic is ALZHEIMER"S DISEASE source
HomePsychologySetting the autism...

Setting the autism record straight on Trump administration claims : Short Wave : NPR


Autism spectrum disorder is still diagnosed by the presence of certain behaviors, including difficulty recognizing social cues, avoiding eye contact, thinking in literal terms, wanting strict routines and having intense but narrowly focused interests. But every autistic person has their own unique constellation of behaviors and characteristics.

DrAfter123/Getty Images


hide caption

toggle caption

DrAfter123/Getty Images

Autism has a long history of misinformation that continues to today. The Trump administration has perpetuated some of this misinformation in the last year. Among other things, officials have claimed certain groups of people don’t get the condition and that taking Tylenol while pregnant causes autism to later develop in children. Today, NPR Science Correspondent Jon Hamilton sets the record straight with host Emily Kwong on what scientists do and don’t know about autism. 

If you liked this episode, check out our episodes on an Autism researcher’s take on Trump’s claims about Tylenol and a Fragile X treatment that may be on the horizon.

Interested in more science in the news? Email us your question at shortwave@npr.org.

Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.

This episode was produced by Berly McCoy. It was edited by Rebecca Ramirez. Tyler Jones checked the facts. The audio engineer was Damian Herring.

Continue reading

Genetic Mismatch Triples Severe Immune Risk

Cord blood transplants are known to tolerate genetic mismatches better than other donor sources. But one specific HLA pairing may sharply raise the risk of severe...

𝗙𝗜𝗥𝗦𝗧 𝗔𝗟𝗭𝗛𝗘𝗜𝗠𝗘𝗥’𝗦 𝗕𝗟𝗢𝗢𝗗 𝗧𝗘𝗦𝗧: 𝗚𝗔𝗠𝗘-𝗖𝗛𝗔𝗡𝗚𝗘𝗥 𝗜𝗡 𝗘𝗔𝗥𝗟𝗬 𝗗𝗜𝗔𝗚𝗡𝗢𝗦𝗜𝗦

Discover how the first FDA-cleared blood test for Alzheimer’s disease, developed by Fujirebio, is transforming early detection and diagnosis. This breakthrough not only simplifies screening but also brings huge economic and clinical value—especially amid shrinking federal funding for Alzheimer’s...

Can Organ Donation Happen After the Heart Stops?

Donation after circulatory death now accounts for nearly half of all deceased organ donors in the United States. Advances in preservation technology are helping make more...